Mission GBM

Mission GBM

Home
Glossary of Terms
Brain Cancer News
Brain Cancer Science Talk
Clinical Trials
FAQs
Goals of Care
Investing in Brain Cancer
Julie's Journey
Meet the Team
Archive
About

August 2024

July 2024

Postcards from the Field
Some green shoots of investing progress as MissionGBM welcomes its 300th case
 • 
Scott L. Rakestraw, PhD
Michael Lim, MD – Brain Cancer Science Talk (Episode 7)
Stanford’s Chair of Neurosurgery discusses the promise and challenges associated with immunotherapy for brain tumors
 • 
Scott L. Rakestraw, PhD
30:07
The Reality of Clinical Trials – Part 2
Bess Stillman, MD details how the Regulatory process needs to be modernized to better serve both cancer patients and Sponsors. We extend the concepts to…
 • 
Scott L. Rakestraw, PhD

June 2024

ASCO 2024: Brain Cancer Highlights
A few potential gems begin to sparkle
 • 
Scott L. Rakestraw, PhD
Anniversary Post: 35 Years, 918 Days…and Counting
A Brain Cancer Diagnosis Can Be a Catalyst to Celebrate Life
 • 
Scott L. Rakestraw, PhD
David D. Tran, MD, PhD – Brain Cancer Science Talk (Episode 6)
An Open-Minded and Curious Physician/Scientist Follows the #Data to Innovate a Compelling Protocol for Treating Gliomas
 • 
Scott L. Rakestraw, PhD
58:11
Glossary of Terms
A Reader-Requested Roadmap of the MissionGBM Abbreviations and Acronyms
 • 
Scott L. Rakestraw, PhD

May 2024

Paul S. Mischel, MD – Brain Cancer Science Talk (Episode 5)
ecDNA, the Importance of Science, #Data and Collaboration, and Upgrading Science in Neuro-Oncology
 • 
Scott L. Rakestraw, PhD
43:30
Meet the Team – Paul S. Mischel, MD
World Class Molecular Oncologist, Invaluable Thought Partner and Complete Mensch
 • 
Scott L. Rakestraw, PhD
News: Erasca Reorganizes and Deprioritizes Development of ERAS-801 for rGBM
Yet Another EGFR-targeted Monotherapy Drops Anchor
 • 
Scott L. Rakestraw, PhD
© 2025 Scott L. Rakestraw, PhD
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture